Hims & Hers Health to introduce generic Liraglutide in 2025 amid growing demand for weight-loss medications The move taps into surging demand for appetite-suppressing GLP-1 agonists, set against ongoing shortages of newer weight-loss options Telehealth firm Hims & Hers Health said on Monday it plans to bring a generic version of Novo Nordisks diabetes drug, liraglutide, to its platform in 2025
Single-arm, non-randomized, time series, single-subject study of fecal microbiota transplantation in multiple sclerosis
Who Benefits Most from B12 Shots for Neuropathy People with severe B12 deficiency or trouble absorbing it orally are best suited for B12 injections
They have been prescribed antacids, told to avoid chilli, and lastly sent home
[Cellular uptake of TPS-L-carnitine synthesised as transporter-based renal targeting [PMID: 23387232] Laboratory literature summary: [Cellular uptake of TPS-L-carnitine synthesised as transporter-based renal targeting prodrug]